| Literature DB >> 21079651 |
Abstract
Since the discovery that deletion of the NF-κB subunits p50 and p52 causes osteopetrosis in mice, there has been considerable interest in the role of NF-κB signaling in bone. NF-κB controls the differentiation or activity of the major skeletal cell types - osteoclasts, osteoblasts, osteocytes and chondrocytes. However, with five NF-κB subunits and two distinct activation pathways, not all NF-κB signals lead to the same physiologic responses. In this review, we will describe the roles of various NF-κB proteins in basal bone homeostasis and disease states, and explore how NF-κB inhibition might be utilized therapeutically.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21079651 PMCID: PMC3193402 DOI: 10.1038/cr.2010.159
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617